Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 265.68 -3.27 (-1.22%) Market Cap: 34.27 Bil Enterprise Value: 33.19 Bil PE Ratio: 0 PB Ratio: 1,062.72 GF Score: 78/100

Alnylam Pharmaceuticals Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 02:40PM GMT
Release Date Price: $183.8 (+1.69%)
Maneka Mirchandaney
Evercore ISI Institutional Equities, Research Division - Analyst

Awesome. Hi, everyone. This is Maneka Mirchandaney from the Evercore ISI biotech team. Very, very thrilled to be here with Alnylam for our next fireside chat at a very exciting time for the company. From the team, we've got Yvonne Greenstreet, who's current President and COO and incoming CEO. So thank you for joining.

Questions & Answers

Maneka Mirchandaney
Evercore ISI Institutional Equities, Research Division - Analyst

And Yvonne, to start, it must be such an exciting time for you. Also, I just want to say how awesome it is to have another female CEO at a leading biotech. But maybe to start, just give us a quick sense for what you've been focused on at Alnylam since you joined in 2016.

Yvonne L. Greenstreet
Alnylam Pharmaceuticals, Inc. - President, COO & Director

Yes, that's great. Thanks, Maneka. And look, it's a pleasure to be here, and thank you so much for having me. It is a real honor to be taking over as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot